In this short review, we describe two new liver-specific contrast agents for MRI that are in clinical development. The main differences among the liver-specific contrast agents available at present are also discussed briefly.
Jan Mintorovitch, PhD
Advertisement
Articles by Jan Mintorovitch, PhD
Advertisement
Latest Updated Articles
Eovist Injection and Resovist Injection: Two New Liver-Specific Contrast Agents for MRIPublished: May 31st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma
3
Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma
4
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
5
